Literature DB >> 2054321

Combining cisplatin and carboplatin complementary or contradictory?

A H Calvert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2054321     DOI： 10.1093/oxfordjournals.annonc.a057889

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

Authors:  A S Planting; M E van der Burg; M de Boer-Dennert; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

2.  A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

Authors:  S Kehoe; C J Poole; A Stanley; H M Earl; G R Blackledge
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.